Müller K M, Menne R, Hüther W, Gröbe H
J Cancer Res Clin Oncol. 1979 Jul 27;94(3):287-94. doi: 10.1007/BF00419288.
Two cases of fatal pneumopathy during cytostatic therapy for acute lymphatic leukemia of childhood, are reported with pathoanatomical lung findings and general clinical features. Histology revealed massed atypical epithelial proliferation in the bronchiolar terminal pathways (tumourlets) with multinucleated polymorphic giant cells beside pulmonary fibrosis. As causative factors for pulmonary chages hypersensitivity reactions, direct toxicity, or pharmacologic effects are discussed. Formal pathogenesis is explained by an impairment of endothelial cells in alveolar capillaries followed by permeability disorders and interstitial edema with disturbed perfusion. Disseminated intravasal microthrombi are frequent. Restitution to integrity appears possible only under favorable conditions. If the exsudative turns into the proliferative phase, intraalveolar and interstitial pulmonary fibrosis may develop with atypical epithelial proliferations. The prognosis of cytostatics-induced pneumopathies depends essentially on the time when it is diagnosied.
报告了两例儿童急性淋巴细胞白血病细胞毒性治疗期间发生的致命性肺病病例,并给出了病理解剖学肺部发现及一般临床特征。组织学检查显示细支气管终末通路(微瘤)存在大量非典型上皮细胞增生,伴有多核多形巨细胞,同时伴有肺纤维化。文中讨论了作为肺部病变病因的超敏反应、直接毒性或药理作用。正式的发病机制解释为肺泡毛细血管内皮细胞受损,随后出现通透性障碍、间质水肿及灌注紊乱。常出现弥漫性血管内微血栓。只有在有利条件下才有可能恢复正常。如果渗出期转变为增殖期,则可能发展为肺泡内及间质肺纤维化,并伴有非典型上皮细胞增生。细胞毒性药物所致肺病的预后主要取决于诊断时间。